Ligand profile
M39
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_19569 — Betaine aldehyde dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
M39- UniProt (similar protein)
P47895- Target protein
- KP13_19569
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 63.6
- −1 ≤ LogP ≤ 5 3.85
- MW ≤ 500 Da 366.4
- LogP ≤ 5 3.85
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 63.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1ccccc1N2C(=O)c3c[nH]nc3N=C2SCc4cccc(c4)FCc1ccccc1N2C(=O)c3c[nH]nc3N=C2SCc4cccc(c4)F
InChI=1S/C19H15FN4OS/c1-12-5-2-3-8-16(12)24-18(25)15-10-21-23-17(15)22-19(24)26-11-13-6-4-7-14(20)9-13/h2-10H,11H2,1H3,(H,21,23)InChI=1S/C19H15FN4OS/c1-12-5-2-3-8-16(12)24-18(25)15-10-21-23-17(15)22-19(24)26-11-13-6-4-7-14(20)9-13/h2-10H,11H2,1H3,(H,21,23)
SSEVBNPAVKLWFQ-UHFFFAOYSA-NSSEVBNPAVKLWFQ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- Active
- Binding sites
- PF00171
External resources
Open this ligand in third-party databases and cheminformatics tools.
- UniProt UniProt P47895 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “M39”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_19569.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 83
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).